Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to evaluate the surgical decisions of Watson artificial intelligence in patients with hepatocellular carcinoma.


Clinical Trial Description

Hepatectomy is an effective treatment for patients with hepatocellular carcinoma, but liver failure after hepatectomy may lead to increased postoperative mortality. Therefore, it is very important to make preoperative surgical decisions, evaluate the safety of the operation and identify which patients are likely to suffer from liver failure. The artificial intelligence platform developed by IBM Watson for Watson tumor treatment decisions can provide treatment decisions and corresponding theoretical basis to guide surgical decisions based on the key clinical data of liver cancer patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03904667
Study type Observational
Source Zhujiang Hospital
Contact
Status Active, not recruiting
Phase
Start date January 1, 2017
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT01960049 - Novel Technique of Analgesia Following Open Liver Resection Phase 4
Terminated NCT01921985 - Terlipressin Administration in Patients Undergoing Major Liver Resection Phase 2
Completed NCT01858987 - Stapler vs. LigaSure in Elective Hepatic Resection N/A
Completed NCT02834338 - Enhanced Perioperative Mobilization (EPM) Trial N/A
Completed NCT02216773 - Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH) N/A
Completed NCT02031094 - Energy Expenditure and Regeneration Following Liver Resection Resection N/A
Recruiting NCT01355887 - A Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure Phase 3
Completed NCT02056028 - Bile Leak After Liver Surgery N/A
Recruiting NCT03917017 - The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma N/A
Recruiting NCT03811704 - Real-time Navigation for Laparoscope Liver Resections Using Fusion 3D Imaging and Indocyanine Green Fluorescence Imaging Phase 2
Completed NCT03171428 - Hepatectomy With or Without the Thoraco-abdominal Approach N/A
Completed NCT01770041 - Paracetamol Metabolism After Liver Surgery N/A
Recruiting NCT04692259 - May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI N/A
Active, not recruiting NCT03600168 - Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery
Recruiting NCT04889235 - Diaphragm Kinetics Following Hepatic Resection